at cancers with defined genetic drivers as well as treatments for conditions like nonalcoholic steatohepatitis and obesity. Terns Pharmaceuticals conducts preclinical research and clinical trials to evaluate safety, efficacy, and dosing of its compounds. The organization collaborates with research partners and contract organizations to support development, regulatory processes, and data generation.